Search research articles
Contact Us
Filters
Showing results (1-10 of 40) with videos related to
Page
of 4
Sort By:
Nature Structural & Molecular Biology
|
November 11, 2021
An online GPCR structure analysis platform
Albert J Kooistra, Christian Munk, Alexander S Hauser, et al.
British Journal of Pharmacology
|
December 22, 2019
Novel approaches leading towards peptide GPCR de-orphanisation
Alexander S Hauser, David E Gloriam, Hans Bräuner-Osborne, et al.
Current Opinion in Pharmacology
|
August 1, 2016
Integrating structural and mutagenesis data to elucidate GPCR ligand binding
Christian Munk, Kasper Harpsøe, Alexander S Hauser, et al.
Frontiers in Medicine
|
September 30, 2021
Glaucoma Clinical Research: Trends in Treatment Strategies and Drug Development
Line Storgaard, Thuy Linh Tran, Josefine Clement Freiberg, et al.
Frontiers in Endocrinology
|
July 5, 2021
Mutational Landscape of the Proglucagon-Derived Peptides
Peter Lindquist, Jakob S Madsen, Hans Bräuner-Osborne, et al.
Critical Reviews in Clinical Laboratory Sciences
|
January 1, 2025
Genetic variants of accessory proteins and G proteins in human genetic disease
Miles D Thompson, Peter Chidiac, Pedro A Jose, et al.
Nature Reviews. Drug Discovery
|
October 28, 2017
Trends in GPCR drug discovery: new agents, targets and indications
Alexander S Hauser, Misty M Attwood, Mathias Rask-Andersen, et al.
Nature
|
May 11, 2017
Selectivity determinants of GPCR-G-protein binding
Tilman Flock, Alexander S Hauser, Nadia Lund, et al.
British Journal of Pharmacology
|
May 10, 2024
Differential G protein activation by the long and short isoforms of the dopamine D<sub>2</sub> receptor
David Reiner-Link, Jakob Sture Madsen, David E Gloriam, et al.
Elife
|
March 18, 2022
Common coupling map advances GPCR-G protein selectivity
Alexander S Hauser, Charlotte Avet, Claire Normand, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 40) with videos related to
Sort By:
Page
of 4
Nature Structural & Molecular Biology
|
November 11, 2021
An online GPCR structure analysis platform
Albert J Kooistra, Christian Munk, Alexander S Hauser, et al.
British Journal of Pharmacology
|
December 22, 2019
Novel approaches leading towards peptide GPCR de-orphanisation
Alexander S Hauser, David E Gloriam, Hans Bräuner-Osborne, et al.
Current Opinion in Pharmacology
|
August 1, 2016
Integrating structural and mutagenesis data to elucidate GPCR ligand binding
Christian Munk, Kasper Harpsøe, Alexander S Hauser, et al.
Frontiers in Medicine
|
September 30, 2021
Glaucoma Clinical Research: Trends in Treatment Strategies and Drug Development
Line Storgaard, Thuy Linh Tran, Josefine Clement Freiberg, et al.
Frontiers in Endocrinology
|
July 5, 2021
Mutational Landscape of the Proglucagon-Derived Peptides
Peter Lindquist, Jakob S Madsen, Hans Bräuner-Osborne, et al.
Critical Reviews in Clinical Laboratory Sciences
|
January 1, 2025
Genetic variants of accessory proteins and G proteins in human genetic disease
Miles D Thompson, Peter Chidiac, Pedro A Jose, et al.
Nature Reviews. Drug Discovery
|
October 28, 2017
Trends in GPCR drug discovery: new agents, targets and indications
Alexander S Hauser, Misty M Attwood, Mathias Rask-Andersen, et al.
Nature
|
May 11, 2017
Selectivity determinants of GPCR-G-protein binding
Tilman Flock, Alexander S Hauser, Nadia Lund, et al.
British Journal of Pharmacology
|
May 10, 2024
Differential G protein activation by the long and short isoforms of the dopamine D<sub>2</sub> receptor
David Reiner-Link, Jakob Sture Madsen, David E Gloriam, et al.
Elife
|
March 18, 2022
Common coupling map advances GPCR-G protein selectivity
Alexander S Hauser, Charlotte Avet, Claire Normand, et al.
Page
of 4